Post-April 15, Where You Live Matters More Than You Think

The April 15 FDA reclassification is a federal action, and federal action sets the floor for compounding pharmacy activity nationwide. State pharmacy board rules, however, set the ceiling — and the variance across states is wider than most consumers realize.

For the majority of U.S. states, the post-April 15 picture is straightforward. A licensed prescriber writes a prescription, a compounding pharmacy in any state with appropriate non-resident licensure fills it, and the patient receives the product. These are the permissive-tier states: Alabama, Arizona, Arkansas, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, Nevada, North Dakota, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, West Virginia, and Wyoming.

A moderate tier — Alaska, Colorado, Delaware, Iowa, Maine, Michigan, Minnesota, New Hampshire, New Mexico, North Carolina, Ohio, Oregon, Pennsylvania, Rhode Island, Virginia, Washington, and Wisconsin — adds one or two verification steps. Expect 7–14 additional days on first order.

The restrictive tier is where practical friction becomes significant: California, Connecticut, Hawaii, Illinois, Maryland, Massachusetts, New Jersey, New York, Vermont, and Washington D.C. These states maintain stricter non-resident pharmacy licensing regimes, limit certain telehealth prescribing workflows, or layer in additional controlled-substance-like oversight on specific peptide categories. California in particular maintains a state-specific non-resident pharmacy registration requirement that several national compounders do not hold.

If you live in a restrictive-tier state, the practical workflow changes: prioritize an in-state compounding pharmacy, expect telehealth prescribing to be limited or unavailable depending on compound, and plan for 2–3x the lead time of a permissive-tier state.

The state-by-state tracker at peptidesbeat.com/tracker/states/ is maintained as a live resource. Check it before placing any order, and before assuming a pharmacy’s advertised state coverage includes yours.